{"id":"W4376645278","doi":"10.3390/curroncol30050381","title":"Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895”","year":2023,"lang":"en","type":"article","venue":"Current Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Ottawa Hospital; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Pertuzumab; Medicine; Breast cancer; Dilemma; Cancer; Internal medicine; Trastuzumab; Epistemology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01888476,0.001374542,0.002342895,0.00181649,0.00625286,0.00482338,0.00530733,0.05370472,0.01658591],"category_scores_gemma":[0.1103249,0.001575172,0.003238146,0.001718427,0.005684384,0.004441294,0.003921199,0.05958111,0.02009247],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01288368,"about_ca_system_score_gemma":0.0207402,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0446046,"about_ca_topic_score_gemma":0.05797929,"domain_scores_codex":[0.9846518,0.003362002,0.001933853,0.001911522,0.006315765,0.001825157],"domain_scores_gemma":[0.9444824,0.02228698,0.003947534,0.001159711,0.02373292,0.00439029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001325969,0.000002295764,0.00005447003,0.00002880224,0.000004076519,0.00006257606,0.00004054309,0.000007358148,0.00002840391,0.0002274352,0.9989753,0.0005556818],"study_design_scores_gemma":[0.00007708112,0.00003211221,0.0009312329,0.0004461785,0.00003741667,0.0003385503,0.0003264868,0.0001006752,0.0002498917,0.00135137,0.9960287,0.00008024736],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.00006550823,0.0006749477,0.0001054965,0.9737215,0.02409836,0.0000340111,0.0002257915,0.00006174704,0.001012605],"genre_scores_gemma":[0.0003360441,0.000340338,0.00009094074,0.9901452,0.00620451,0.00006255053,0.00004854578,0.00002696548,0.002745004],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.9871163,"threshold_uncertainty_score":0.09987336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1205007599644146,"score_gpt":0.4851498856374528,"score_spread":0.3646491256730382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}